CME Group Inc. (NASDAQ:CME) Shares Bought by Meadow Creek Wealth Advisors LLC

Meadow Creek Wealth Advisors LLC grew its position in shares of CME Group Inc. (NASDAQ:CME) by 3.7% during the 3rd quarter, according to its most recent filing with the Securities and Exchange Commission (SEC). The fund owned 3,191 shares of the financial services provider’s stock after purchasing an additional 114 shares during the period. Meadow Creek Wealth Advisors LLC’s holdings in CME Group were worth $704,000 at the end of the most recent quarter.

Several other hedge funds also recently modified their holdings of the company. Capital International Investors boosted its stake in shares of CME Group by 24.1% during the 1st quarter. Capital International Investors now owns 15,809,175 shares of the financial services provider’s stock worth $3,403,557,000 after purchasing an additional 3,069,806 shares during the last quarter. Ameriprise Financial Inc. boosted its stake in shares of CME Group by 11.3% during the 2nd quarter. Ameriprise Financial Inc. now owns 5,283,196 shares of the financial services provider’s stock worth $1,038,676,000 after purchasing an additional 537,758 shares during the last quarter. GUARDCAP ASSET MANAGEMENT Ltd boosted its stake in shares of CME Group by 1.1% during the 1st quarter. GUARDCAP ASSET MANAGEMENT Ltd now owns 4,009,068 shares of the financial services provider’s stock worth $863,112,000 after purchasing an additional 43,293 shares during the last quarter. Raymond James & Associates boosted its stake in shares of CME Group by 3.2% during the 2nd quarter. Raymond James & Associates now owns 3,029,145 shares of the financial services provider’s stock worth $595,530,000 after purchasing an additional 94,302 shares during the last quarter. Finally, Legal & General Group Plc boosted its stake in shares of CME Group by 6.6% during the 2nd quarter. Legal & General Group Plc now owns 2,835,075 shares of the financial services provider’s stock worth $557,371,000 after purchasing an additional 176,004 shares during the last quarter. 87.75% of the stock is owned by institutional investors and hedge funds.

Insider Activity

In other news, Director Bryan T. Durkin sold 7,593 shares of CME Group stock in a transaction that occurred on Friday, August 30th. The shares were sold at an average price of $214.59, for a total transaction of $1,629,381.87. Following the sale, the director now owns 55,607 shares in the company, valued at $11,932,706.13. This trade represents a 0.00 % decrease in their ownership of the stock. The transaction was disclosed in a document filed with the SEC, which is available at this hyperlink. In other news, CFO Lynne Fitzpatrick sold 754 shares of the business’s stock in a transaction on Sunday, September 15th. The shares were sold at an average price of $216.99, for a total transaction of $163,610.46. Following the completion of the transaction, the chief financial officer now owns 13,261 shares of the company’s stock, valued at approximately $2,877,504.39. The trade was a 0.00 % decrease in their ownership of the stock. The sale was disclosed in a legal filing with the SEC, which can be accessed through the SEC website. Also, Director Bryan T. Durkin sold 7,593 shares of the business’s stock in a transaction on Friday, August 30th. The shares were sold at an average price of $214.59, for a total transaction of $1,629,381.87. Following the transaction, the director now directly owns 55,607 shares of the company’s stock, valued at approximately $11,932,706.13. This trade represents a 0.00 % decrease in their position. The disclosure for this sale can be found here. Insiders own 0.30% of the company’s stock.

Wall Street Analyst Weigh In

CME has been the topic of several analyst reports. Morgan Stanley raised their price target on shares of CME Group from $210.00 to $233.00 and gave the stock an “equal weight” rating in a research note on Thursday, October 17th. Barclays raised their target price on shares of CME Group from $209.00 to $219.00 and gave the stock an “equal weight” rating in a research report on Monday, October 7th. The Goldman Sachs Group raised their target price on shares of CME Group from $195.00 to $198.00 and gave the stock a “sell” rating in a research report on Thursday, October 3rd. Citigroup raised their target price on shares of CME Group from $240.00 to $250.00 and gave the stock a “buy” rating in a research report on Thursday, October 3rd. Finally, JPMorgan Chase & Co. raised their target price on shares of CME Group from $187.00 to $191.00 and gave the stock an “underweight” rating in a research report on Thursday, July 25th. Four research analysts have rated the stock with a sell rating, seven have assigned a hold rating and four have given a buy rating to the stock. According to data from MarketBeat, the stock has a consensus rating of “Hold” and a consensus target price of $220.07.

CME Group Trading Down 1.1 %

CME opened at $223.75 on Wednesday. The firm has a market capitalization of $80.56 billion, a P/E ratio of 25.73, a P/E/G ratio of 7.76 and a beta of 0.55. The firm’s 50 day moving average is $217.70 and its 200-day moving average is $208.53. CME Group Inc. has a 52-week low of $190.70 and a 52-week high of $230.12. The company has a quick ratio of 1.02, a current ratio of 1.02 and a debt-to-equity ratio of 0.10.

CME Group (NASDAQ:CME) last posted its quarterly earnings data on Wednesday, July 24th. The financial services provider reported $2.56 earnings per share (EPS) for the quarter, beating analysts’ consensus estimates of $2.53 by $0.03. The company had revenue of $1.53 billion for the quarter, compared to analyst estimates of $1.53 billion. CME Group had a net margin of 56.98% and a return on equity of 12.82%. The business’s quarterly revenue was up 12.7% on a year-over-year basis. During the same quarter last year, the firm posted $2.30 earnings per share. Analysts expect that CME Group Inc. will post 10.04 EPS for the current fiscal year.

CME Group Dividend Announcement

The company also recently disclosed a quarterly dividend, which was paid on Wednesday, September 25th. Stockholders of record on Monday, September 9th were paid a dividend of $1.15 per share. The ex-dividend date was Monday, September 9th. This represents a $4.60 dividend on an annualized basis and a dividend yield of 2.06%. CME Group’s dividend payout ratio is currently 52.33%.

CME Group Company Profile

CME Group Inc, together with its subsidiaries, operates contract markets for the trading of futures and options on futures contracts worldwide. It offers futures and options products based on interest rates, equity indexes, foreign exchange, agricultural commodities, energy, and metals, as well as fixed income and foreign currency trading services.